Showing results (51-60 of 401) with videos related to
Sort By:
Pageof 41
International Archives of Allergy and Applied Immunology|January 1, 1989
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin AM Triggiani, R Cirillo, L M Lichtenstein, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cellB J Undem, P T Peachell, L M LichtensteinMonographs in Allergy|January 1, 1977
Protection against anaphylaxis in hymenoptera-sensitive patients by passive immunizationM H Lessof, A K Sobotka, L M LichtensteinThe American Review of Respiratory Disease|May 1, 1987
A comparison of the osmotic activation of basophils and human lung mast cellsP A Eggleston, A Kagey-Sobotka, L M LichtensteinThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cellsJ A Warner, L M Lichtenstein, D W MacGlashanJournal of Immunology (Baltimore, Md. : 1950)|June 1, 1976
Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187M C Conroy, R P Orange, L M LichtensteinThe Journal of Investigative Dermatology|May 1, 1980
Basophil mediators and their release, with emphasis on BK-AH H Newball, H L Meier, L M LichtensteinFederation Proceedings|January 1, 1982
Role of receptor aggregation in triggering IgE-mediated reactionsA Kagey-Sobotka, D W MacGlashan, L M LichtensteinDigestive Diseases and Sciences|February 1, 1991
Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acidC C Fox, W C Moore, L M LichtensteinThe Journal of Pharmacology and Experimental Therapeutics|July 1, 1986
Mediator release from human lung under conditions of reduced oxygen tensionS P Peters, L M Lichtenstein, N F AdkinsonPageof 41